#dilatedcardiomyopathytherapeuticsmarketshare
Text
Dilated Cardiomyopathy Therapeutics Market Size, Growth, Trends, Share, Forecast 2020-2026
The global dilated cardiomyopathy (DCM) therapeutics market is anticipated to grow with a significant CAGR of 8% during the forecast period. DCM is one of the prevalent causes of heart failure in adult patients and represents the most common diagnosis leading to a heart transplant in children. The advancements in healthcare and the introduction of new modern techniques are reducing the challenges for the treatment of pediatric DCM. In addition to this, better understanding the pathogenesis of pediatric DCM and the development of effective therapies outside of cardiac transplantation is also driving the DCM therapeutics market.
Request a Free Sample of our Report on Dilated Cardiomyopathy Therapeutics Market: https://www.omrglobal.com/industry-reports/dilated-cardiomyopathy-dcm-therapeutics-market
Furthermore, stem cell and cell-based therapies are offering an innovative approach to restore cardiac structure and function towards normal in pediatric patients. This is possibly reducing the need for aggressive therapies and cardiac transplantation. Hence, a systematic investigation needs to be done by the medical community which will benefit current and novel treatments for pediatric DCM.
For instance, mesenchymal stem cells and cardiac stem cells are found to be the most promising cell types for treating children with dilated cardiomyopathy. Therefore, the increasing research activities for stem cell and cell-based therapies are anticipated to drive the DCM therapeutic market significantly during the forecast period.
Moreover, the combination of complementary and alternative medicines as adjunctive therapy is also anticipated to benefit DCM patients. For instance, the combination of conventional medical treatment and oral Chinese herbal medicine is representing exciting adjunctive therapies for the DCM. Several of the effective Chinese drugs pharmaceutics for treating DCM includes Huangqi injection, Qiliqiangxin Capsule, and Shenfu injection.
This is also anticipated to drive the DCM therapeutics industry share, especially in the Asia-Pacific region. Some of the key players active in the global DCM therapeutics market include Binance, Bitstamp Ltd., Blockstream Corp. Inc., BlockCypher, Inc., Coinbase UK, Ltd., Luno Pte. Ltd., BitMain Technologies Holding Co., and others. By witnessing the opportunity in the market, multiple companies have been successful to secure funding to increase their R&D activities and product portfolio in the DCM therapeutics market.
A Full Report of Dilated Cardiomyopathy Therapeutics Market is Available at https://www.omrglobal.com/industry-reports/dilated-cardiomyopathy-dcm-therapeutics-market
Global DCM Therapeutics Market- Segmentation
By Drug Class
Angiotensin-Converting Enzyme (ACE) Inhibitors
Beta-Blockers
Aldosterone Antagonists
Digitalis
Angiotensin II Receptor blockers
Anticoagulants
By Therapy Devices
Implantable Cardioverter-Defibrillators (ICDs)
Biventricular Pacemakers
Heart Pumps
Global DCM Therapeutics Market- Segment by Region
North America
The US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East Africa
Company Profiles
· Abbott Laboratories
· Berlin Cures GmbH
· Capricor Therapeutics, Inc.
· Cardiol Therapeutics Inc.
· Celixir plc
· CENTOGENE N.V.
· Heartseed Inc.
· Medtronic plc
· Merck & Co., Inc.
· MyoKardia, Inc.
· Novartis AG
· Pfizer Inc.
· Renovacor, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dilated-cardiomyopathy-dcm-therapeutics-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
0 notes
Photo
The global dilated cardiomyopathy (DCM) therapeutics market is anticipated to grow with a significant CAGR of 8% during the forecast period. DCM is one of the prevalent causes of heart failure in adult patients and represents the most common diagnosis leading to a heart transplant in children. The advancements in healthcare and the introduction of new modern techniques are reducing the challenges for the treatment of pediatric DCM. Browse Full Report at https://www.omrglobal.com/industry-reports/dilated-cardiomyopathy-dcm-therapeutics-market
#dilatedcardiomyopathytherapeuticsmarket#dilatedcardiomyopathytherapeuticsmarketsize#dilatedcardiomyopathytherapeuticsmarketshare
0 notes
Last Seen Blogs
